## Clinical Context: Weil's Disease (Severe Leptospirosis) The patient has progressed to **Weil's disease** (immune phase, severe leptospirosis): - **Day 8 of illness** (immune phase begins ~day 5–7) - **Jaundice** (hepatic dysfunction) - **Acute kidney injury** (creatinine 3.2 mg/dL — renal failure) - **Pulmonary infiltrates with crackles** (pulmonary hemorrhage/ARDS) - **Positive serology (MAT 1:1600)** — confirms immune phase - **Negative blood culture** — consistent with immune phase (organisms cleared from blood) ## Rationale for Correct Answer **Key Point:** For **severe leptospirosis (Weil's disease)** with multi-organ failure, **intravenous Penicillin G** is the **first-line, gold-standard antibiotic** per Harrison's Principles of Internal Medicine (21e, Ch 197) and WHO guidelines. The standard dose is **1.5 million units IV every 6 hours** (total ~6 MU/day) or up to **18 million units/day** in divided doses for severe disease. **High-Yield:** - **Penicillin G IV** is the drug of choice for severe leptospirosis — supported by the largest body of evidence and explicitly recommended in Harrison's and WHO guidelines. - **Ceftriaxone** is an acceptable *alternative* when penicillin is unavailable or contraindicated, but it is NOT the preferred first-line agent over Penicillin G in standard guidelines. - The dose of **ceftriaxone 1 g IV four times daily (QID)** stated in Option B is also non-standard — the evidence-based dose for leptospirosis is **1 g IV once daily**, not QID. This makes Option B doubly incorrect. - **Doxycycline** (oral or IV) is appropriate for mild-to-moderate leptospirosis but is relatively contraindicated in severe AKI and is not the preferred agent for Weil's disease. - **Hemodialysis** may be required for AKI, but the creatinine of 3.2 mg/dL alone does not mandate *immediate* hemodialysis — clinical criteria (oliguria, hyperkalemia, uremia, acidosis) guide this decision. The "arrange hemodialysis" framing in Option B is premature without additional clinical criteria. ## Antibiotic Selection in Leptospirosis | Severity | First-Line Agent | Dosing | Notes | |----------|------------------|--------|-------| | **Mild–moderate** | Doxycycline | 100 mg PO BD × 7 days | Oral acceptable | | **Severe (Weil's disease)** | **Penicillin G IV** | 1.5 MU IV q6h (or 18 MU/day in divided doses) | **Drug of choice** | | **Severe (alternative)** | Ceftriaxone IV | 1 g IV once daily | If penicillin unavailable/allergic | | **Severe (alternative)** | Ampicillin IV | 500–1000 mg IV q6h | Acceptable alternative | ## Why NOT Option B (Ceftriaxone QID + hemodialysis)? **Warning:** Option B contains two errors: 1. **Ceftriaxone is a second-line alternative**, not the preferred agent over Penicillin G for severe leptospirosis per Harrison's and WHO guidelines. 2. **Ceftriaxone dosing for leptospirosis is 1 g IV once daily** — not four times daily (QID). The QID dosing is incorrect and non-standard. 3. Immediate hemodialysis is not mandated by a creatinine of 3.2 mg/dL alone without additional uremic criteria. ## Clinical Pearl **Clinical Pearl:** In NEET PG/INI-CET, for severe leptospirosis (Weil's disease), **Penicillin G IV** is the textbook answer. Ceftriaxone is mentioned as an alternative in some guidelines (Cochrane review, Panaphut et al. 2003), but Penicillin G remains the standard first-line recommendation in Harrison's 21e and WHO guidelines for severe disease. [cite: Harrison 21e Ch 197; WHO Leptospirosis Guidelines; Panaphut T et al. Ceftriaxone compared with sodium penicillin G for treatment of severe leptospirosis. Clin Infect Dis. 2003]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.